Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Pharmacokinetic (PK) Exposure of 4-Hydroxycyclophosphamide Associates with Clinical Benefits of Reduced-Dose Post-Transplantation Cyclophosphamide: Results of a Completed Phase I/II Trial to De-Escalate Post-Transplantation Cyclophosphamide for HLA-Haploidentical Myeloablative Bone Marrow Transplantation

Blood (2024) 144 (Supplement 1): 1040.

https://doi.org/10.1182/blood-2024-212138

Published: 2024

Journal Articles

Phase I/II Study of Reduced Dosing of Post-Transplantation Cyclophosphamide (PTCy) after HLA-Haploidentical Bone Marrow Transplantation

Meredith J. McAdams, Mustafa Hyder, Dimana Dimitrova, Jennifer L. Sadler, Christi McKeown, Seth M. Steinberg, Amy Chai, Scott Napier, Anita Stokes, Jennifer Sponaugle, Thomas E. Hughes, Nu Ri Cha, Jennifer Cuellar-Rodriguez, Melissa Walker, Ronald E. Gress, Jennifer A. Kanakry, Christopher G. Kanakry

Blood (2021) 138 (Supplement 1): 101.

https://doi.org/10.1182/blood-2021-146997

Published: 2021

Journal Articles

Allogeneic Hematopoietic Stem-Cell Transplantation in Patients with GATA 2 Deficiency: Influence of Donor Stem Cell Source and Post-Transplantation Cyclophosphamide

Diana X. Nichols-Vinueza, MD, Nirali N. Shah, MD, Jennifer Cuellar-Rodriguez, MD, Thomas R. Bauer, Jr., PhD, Katherine R. Calvo, MD PhD, Luigi D. Notarangelo, MD, Steven M. Holland, MD, Dennis D. Hickstein, MD

Blood (2020) 136 (Supplement 1): 37–38.

https://doi.org/10.1182/blood-2020-138535

Published: 2020

Journal Articles

GATA2 deficiency-associated bone marrow disorder differs from idiopathic aplastic anemia

Karthik A. Ganapathi, Danielle M. Townsley, Amy P. Hsu, Diane C. Arthur, Christa S. Zerbe, Jennifer Cuellar-Rodriguez, Dennis D. Hickstein, Sergio D. Rosenzweig, Raul C. Braylan, Neal S. Young, Steven M. Holland, Katherine R. Calvo

Blood (2015) 125 (1): 56–70.

https://doi.org/10.1182/blood-2014-06-580340

Published: 2015

Journal Articles

Hemophagocytic Lymphohistiocytosis Associated with NK Cell Dysfunction and Disseminated Herpesvirus Infection in GATA2 Deficiency/Monomac Syndrome

Michael A. Spinner, MD, Camila Odio, B.S., Katherine R. Calvo, MD, PhD, Amy P Hsu, B.A., Christa S. Zerbe, MD, Jennifer Cuellar-Rodriguez, MD, Jennifer P. Ker, MD, Charles J. Stoudenmire, MD, Oluwole Fadare, MD, Arunima Ghosh, MD,PhD, Emily M. Mace, PhD, Jordan S. Orange, MD, PhD, Dennis D. Hickstein, MD, Steven M. Holland, MD

Blood (2014) 124 (21): 4978.

https://doi.org/10.1182/blood.V124.21.4978.4978

Published: 2014

Journal Articles

Nonmyeloablative Versus Myeloablative Allogeneic Hematopoietic Stem Cell Transplant for GATA2 Deficiency

Jennifer Cuellar-Rodriguez, MD, Dennis D. Hickstein, MD, Jennifer K. Grossman, MD BSc, Mark Parta, MD, Juan Gea-Banacloche, MD, Christa S. Zerbe, MD, Alexandra F Freeman, MD, Steven M. Holland, MD, Katherine R. Calvo, MD, PhD

Blood (2014) 124 (21): 1247.

https://doi.org/10.1182/blood.V124.21.1247.1247

Published: 2014

Journal Articles

Successful Haploidentical Hematopoietic Stem Cell Transplant for GATA2 Deficiency

Christa S. Zerbe, MD, Jennifer Cuellar-Rodriguez, MD, Juan Gea-Banacloche, MD, Steven M. Holland, MD, Dennis D. Hickstein, MD

Blood (2014) 124 (21): 5838.

https://doi.org/10.1182/blood.V124.21.5838.5838

Published: 2014

Journal Articles

GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity

Blood (2014) 123 (6): 809–821.

https://doi.org/10.1182/blood-2013-07-515528

Published: 2014

Includes: Supplemental data

Journal Articles

Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplant For GATA2 Deficiency

Jennifer Cuellar-Rodriguez, M.D., Juan Gea-Banacloche, MD, Christa Zerbe, MD, Terry J Fry, MD, Kristin Baird, MD, Steven M. Holland, MD, Dennis D. Hickstein, M.D.

Blood (2013) 122 (21): 2113.

https://doi.org/10.1182/blood.V122.21.2113.2113

Published: 2013

Journal Articles

Allogeneic Hematopoietic Stem Cell Transplant Reverses The Phenotype Of DOCK8 Deficiency

Jennifer Cuellar-Rodriguez, M.D., Alexandra F Freeman, MD, Juan Gea-Banacloche, MD, Helen Su, MD, PHD, Jennifer K. Grossman, MD, BSc, Terry J Fry, MD, Steven M. Holland, MD, Dennis D. Hickstein, M.D.

Blood (2013) 122 (21): 2114.

https://doi.org/10.1182/blood.V122.21.2114.2114

Published: 2013

Journal Articles

Very Short Telomeres As a Novel Mechanism Of Donor-Cell Derived Leukemia After Cord Blood Transplantation

Bogdan Dumitriu, MD, Yasutaka Ueda, MD, PhD, Sachiko Kajigaya, PhD, Danielle Townsley, MD, Jennifer Cuellar Rodriguez, MD, Dennis D. Hickstein, M.D., Neal S. Young, MD

Blood (2013) 122 (21): 1245.

https://doi.org/10.1182/blood.V122.21.1245.1245

Published: 2013

Journal Articles

GATA2 haploinsufficiency caused by mutations in a conserved intronic element leads to MonoMAC syndrome

Amy P. Hsu, Kirby D. Johnson, E. Liana Falcone, Rajendran Sanalkumar, Lauren Sanchez, Dennis D. Hickstein, Jennifer Cuellar-Rodriguez, Jacob E. Lemieux, Christa S. Zerbe, Emery H. Bresnick, Steven M. Holland

Blood (2013) 121 (19): 3830–3837.

https://doi.org/10.1182/blood-2012-08-452763

Published: 2013

Includes: Supplemental data

Journal Articles

ASXL1 mutations in GATA2 -Deficiency Correlate with Leukemic Transformation

Robert R. West, Ph.D., Amy Hsu, B.S., Katherine R. Calvo, MD, PhD, Jennifer Cuellar-Rodriguez, M.D., Steven M. Holland, MD, Dennis D. Hickstein, M.D.

Blood (2012) 120 (21): 405.

https://doi.org/10.1182/blood.V120.21.405.405

Published: 2012

Journal Articles

Allogeneic Hematopoietic Stem Cell Transplant Reverses the Phenotype of GATA2 Deficiency.

Jennifer Cuellar-Rodriguez, M.D., Juan Gea-Banacloche, MD, Amy P Hsu, BA, Christa Zerbe, MD, Alexandra Freeman, MD, Kenneth N Olivier, Katherine R Calvo, MD, PhD, Terry J Fry, MD, Steven M. Holland, MD, Dennis D. Hickstein, M.D.

Blood (2012) 120 (21): 3091.

https://doi.org/10.1182/blood.V120.21.3091.3091

Published: 2012

Journal Articles

Loss-of-function germline GATA2 mutations in patients with MDS/AML or MonoMAC syndrome and primary lymphedema reveal a key role for GATA2 in the lymphatic vasculature

Blood (2012) 119 (5): 1283–1291.

https://doi.org/10.1182/blood-2011-08-374363

Published: 2012

Includes: Supplemental data

Journal Articles

Successful allogeneic hematopoietic stem cell transplantation for GATA2 deficiency

Jennifer Cuellar-Rodriguez, Juan Gea-Banacloche, Alexandra F. Freeman, Amy P. Hsu, Christa S. Zerbe, Katherine R. Calvo, Jennifer Wilder, Roger Kurlander, Kenneth N. Olivier, Steven M. Holland, Dennis D. Hickstein

Blood (2011) 118 (13): 3715–3720.

https://doi.org/10.1182/blood-2011-06-365049

Published: 2011

Journal Articles

Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome

Blood (2011) 118 (10): 2653–2655.

https://doi.org/10.1182/blood-2011-05-356352

Published: 2011

Includes: Supplemental data

NARROW

Phase I/II Study of Reduced Dosing of Post-Transplantation Cyclophosphamide (PTCy) after HLA-Haploidentical Bone Marrow Transplantation

Allogeneic Hematopoietic Stem-Cell Transplantation in Patients with GATA 2 Deficiency: Influence of Donor Stem Cell Source and Post-Transplantation Cyclophosphamide

GATA2 deficiency-associated bone marrow disorder differs from idiopathic aplastic anemia

Hemophagocytic Lymphohistiocytosis Associated with NK Cell Dysfunction and Disseminated Herpesvirus Infection in GATA2 Deficiency/Monomac Syndrome

Nonmyeloablative Versus Myeloablative Allogeneic Hematopoietic Stem Cell Transplant for GATA2 Deficiency

Successful Haploidentical Hematopoietic Stem Cell Transplant for GATA2 Deficiency

GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity

Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplant For GATA2 Deficiency

Allogeneic Hematopoietic Stem Cell Transplant Reverses The Phenotype Of DOCK8 Deficiency

Very Short Telomeres As a Novel Mechanism Of Donor-Cell Derived Leukemia After Cord Blood Transplantation

GATA2 haploinsufficiency caused by mutations in a conserved intronic element leads to MonoMAC syndrome

ASXL1 mutations in GATA2 -Deficiency Correlate with Leukemic Transformation

Allogeneic Hematopoietic Stem Cell Transplant Reverses the Phenotype of GATA2 Deficiency.

Loss-of-function germline GATA2 mutations in patients with MDS/AML or MonoMAC syndrome and primary lymphedema reveal a key role for GATA2 in the lymphatic vasculature

Successful allogeneic hematopoietic stem cell transplantation for GATA2 deficiency

Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only